Whilst this is true, I've always seen the advancement of SB to be favourable as it only creates further exposure for Botanix as a whole.
It may even make things easier as we start to apply for Sofdra approvals throughout territories which Kaken do not manage. Also provides us with a case study to sell licensing in areas we might not want to actively control/manage ourselves..
Just my opinion
BOT - Anything but charting, page-10570
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.010(2.41%) |
Mkt cap ! $770.9M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 43.0¢ | 41.5¢ | $2.549M | 6.044M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3910 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 69754 | 2 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |